AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israel searches for technology that could find soldiers and pilots who cannot call for help
2
Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount
3
After IAI and Rafael, secretive missile engine maker Tomer moves toward an IPO
4
ServiceNow continues layoffs as it restructures around AI
5
Israel's Iron Dome and Arrow makers unlikely to reach the IPO market before 2027 as Tomer joins the queue
More news

Private Equity

20 stories about Private Equity
מגזין מנהלים ישי דוידי מייסד יו"ר ומנכ"ל קרן ההשקעות פימי

FIMI raises record $1.75 billion for largest fund in its history

13.07.26|Golan Hazani
Israel's biggest private equity firm exceeded its fundraising target despite nearly three years of war and continued geopolitical uncertainty.
ישי דוידי מייסד קרן פימי ו גילון בק שותף בכיר בקרן

The numbers behind FIMI: Zim deal lifts the veil on Israel’s private equity giant

24.03.26|Golan Hazani
Rare financial disclosures tied to the $4.2 billion Zim deal reveal $698 million in annual profit and outsized returns driven by defense investments.
Aviram Kalev Eden Global Partners

“Innovation remains the foundation, but it's the resilience that's earning Israeli tech a premium”

18.03.26|Amy Shapiro, Elihay Vidal
Eden Global Partners joined CTech as part of its IL Tech in NY series in collaboration with Israeli Mapped in NY.
Dean Sysman

The SaaS reckoning reaches private equity

09.02.26|Sophie Shulman
AI-driven repricing turns once-coveted software portfolios into a growing liability.
מימין מייסדי אפספלייר אורן קניאל ו רשף מן

AppsFlyer nears $2 billion sale to Apollo and Fortissimo

06.01.26|Sophie Shulman
Private equity funds step in as valuation matches company’s last funding round.
מימין חגי שטדלר , שמואל וולדינגר , ישראל שליסר ו אייל חברוני

After a $100 million profit windfall, AP Partners sets its sights on a $400 million fund

28.12.25|Almog Azar
EXCLUSIVE: The Israeli private equity firm closes two exits in December and moves to scale up its next fundraising round.
Noam Canetti Yifat Oron Rob Levy and Yoav Hinman Private Equity MNC Summit 2025

Israel is “on par” with Silicon Valley, says Blackstone’s Yifat Oron

06.11.25|Amy Shapiro
As Israel’s startup ecosystem matures beyond premature exits, a panel of private equity experts argues that PE is becoming increasingly pivotal in elevating Startup Nation toward fulfilling its potential for scale and growth.
עו"ד נמרוד רוזנבלום משרד אפשטיין רוזנבלום מעוז

The titans are back: Foreign private equity funds show renewed presence in Israel

29.10.25|Nimrod Rosenblum
"Foreign equity has not disappeared; it simply evolved. Beyond the flashy Nasdaq exits, a new wave of steady, meaningful private equity transactions is reshaping the market," writes Nimrod Rosenblum, Managing Partner and Head of Corporate, Mergers & Acquisitions at Epstein Rosenblum Maoz (ERM) Law Firm.
Tomer Raved

Foreign private equity funds: A critical pillar in the maturation of Israel’s business sector

08.09.25|Tomer Raved
Smart foreign capital that recognizes the resilience and maturity of Israeli companies, even amid persistent security uncertainty, can strengthen traditional industries, reduce leverage, and firmly position Israel on the global growth map.
etoro איטורו פתחת המסחר נאסד"ק 3

Tectonic shifts are forcing venture capital to abandon the traditional model to survive

03.06.25|Meir Orbach, Sophie Shulman
The collapse of the classic startup playbook is forcing a fundamental reinvention. 
מימין מנהל השקעות ראשי קבוצת הפניקס חגי שרייבר ו אלעד גבעוני

Are Israel’s institutional investors late to the tech investment party?

24.03.21|Golan Hazani
Senior executives at The Phoenix explain their strategy when it comes to investments in private companies and admit they missed the insurtech craze
ליסיה בכר מנוח שותפה קרן קטליסט

Tel Aviv-based equity firm Catalyst appoints Lisya Bahar-Manoah as partner

03.08.20|Sophie Shulman
Before joining Catalyst, Bahar-Manoah held senior management positions at Israeli plastic products company Keter and pesticide manufacturer Adama
כנס פינטק 15.5.18 פאנל דור ההשקעות יפעת אורון

As Capital Flows and Market Matures, Israeli Entrepreneurs Dream Big

05.11.18|Hagar Ravet
While tech companies’ choose to stay private longer, a record number of privately held growth companies now call Israel home, some with a valuation topping $1 billion
תל אביב קו רקיע Tel Aviv Skyline

Venture Capital Investments in Israel in 2018 on Track to Match or Outpace 2017

02.10.18|CTech
Private equity deals are also picking up again after last year, with a shift from IT to healthcare, according to a new analysis by Pitchbook editor Eric Burg
כנס כלכליסט ניו יורק גף הורינג

Israel is One of the Most Interesting Markets for Investment, Says Venture Capitalist Jeff Horing

19.03.18|Omer Kabir
“Israel is the highest density geography in our portfolio,” Mr. Horing, co-founder and managing director at Insight Venture Partners, said at Calcalist's Mind the Tech conference in New York
אילן רוזן HarbourVest Partners

Private Equity Firm HarbourVest Announces Series of Promotions

05.03.18|Tofi Stoler
Among those promoted is Ilan Rosen, head of HarbourVest’s Tel Aviv office
אלגוסק algosec יובל בר און

Data Security Company Algosec Raises $36 Million

03.01.18|Tofi Stoler
The investment was led by private equity firm Claridge Israel, the local branch of international firm Claridge Investment Ltd.
default image

Warburg Pincus Completes Tender Offer for Email Protection Company Cyren

26.12.17|Lilach Baumer
After payment, the private equity firm will own approximately 52% of outstanding Cyren Shares
default image

Warburg Pincus Buys Stake in Email Protection Company Cyren

07.11.17|Dror Reich
The private equity acquired a 21.3% stake in Nasdaq-listed Cyren for $19.6 million and plans to increase ownership by buying up to 75% of the company’s shares
מפעל טבע הר חוצבים ירושלים

Cerberus, Advent Eye Teva's European Assets, Report Says

15.08.17|Calcalist
The private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report